Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $68.49 $68.49 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $68.49 $68.49
52 weeks $21.65 $73.02

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Jan 02, 2019 $40.19 $41.46 $40.00 $41.13 743 192
Dec 31, 2018 $40.76 $41.65 $40.02 $41.05 715 083
Dec 28, 2018 $39.73 $40.94 $38.56 $40.03 661 660
Dec 27, 2018 $39.32 $40.84 $37.67 $39.90 798 270
Dec 26, 2018 $37.59 $40.06 $37.40 $40.00 1 092 907
Dec 24, 2018 $34.92 $37.85 $34.92 $37.56 556 927
Dec 21, 2018 $37.99 $38.05 $34.96 $35.86 2 766 522
Dec 20, 2018 $38.00 $39.05 $36.40 $37.72 1 340 415
Dec 19, 2018 $41.27 $42.90 $37.36 $38.68 1 076 583
Dec 18, 2018 $42.15 $42.49 $40.24 $40.95 1 183 993
Dec 17, 2018 $42.09 $43.24 $41.45 $41.57 1 053 429
Dec 14, 2018 $42.09 $43.19 $41.55 $42.24 965 174
Dec 13, 2018 $43.38 $43.95 $41.92 $42.61 619 467
Dec 12, 2018 $43.54 $43.88 $42.00 $43.23 794 861
Dec 11, 2018 $43.98 $44.10 $42.26 $42.77 1 089 747
Dec 10, 2018 $43.00 $43.54 $41.27 $43.38 1 373 930
Dec 07, 2018 $44.00 $44.60 $41.51 $42.66 4 168 638
Dec 06, 2018 $44.87 $48.51 $43.81 $46.67 2 145 252
Dec 04, 2018 $46.01 $48.32 $44.81 $45.45 3 944 836
Dec 03, 2018 $44.06 $50.11 $39.80 $46.62 11 968 525
Nov 30, 2018 $32.08 $32.70 $30.15 $31.54 1 508 754
Nov 29, 2018 $32.74 $33.83 $31.98 $32.01 1 116 574
Nov 28, 2018 $32.43 $32.89 $31.85 $32.80 1 043 972
Nov 27, 2018 $33.59 $34.07 $32.00 $32.06 1 042 060
Nov 26, 2018 $34.64 $35.27 $32.98 $33.81 700 998
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT